RKLB — Rocket Lab USA
Rocket Lab has built a genuinely impressive launch and space systems business — $602 million in FY2025 revenue growing at 38%, a $1.85 billion backlog, and a 21-launch year with 100% mission success — but the company trades at an enterprise value of approximately $38.8 billion, a multiple of 65 times revenue, priced entirely around a medium-lift rocket called Neutron that has not yet flown and that suffered a tank test failure in its development program. The CFO sold over $103 million in shares in January 2026, and the company raised $1.15 billion through equity dilution in 2025 followed immediately by a $1 billion offering in 2026; the business that exists today cannot support the valuation, and the business required to support it — Neutron succeeding, winning the national security launch qualification, and capturing significant market share against SpaceX — has not been demonstrated. Avoid.
The commercial and government space launch market is undergoing a genuine structural expansion. The proliferation of low-earth-orbit satellite constellations — for broadband, defense surveillance, imaging, and communications — is creating sustained and growing demand for launch services at a rate that was not anticipated even five years ago. The U.S. Space Force has made explicit its intention to diversify away from sole-source dependence on a single launch provider, creating a policy environment that is structurally favorable for any credible domestic alternative. Defense spending on space assets is growing at approximately 30% per year by some estimates, and the Space Development Agency's multi-billion-dollar constellation programs have created a category of government customer that buys not just launches but entire satellite systems — hardware, software, orbital management — from a single prime contractor. The macro environment for space infrastructure companies is about as favorable as it has been in the industry's commercial history.
The commercial space launch market was valued at approximately $15 billion annually in 2025 and is projected to grow at double-digit rates through the early 2030s, driven primarily by constellation deployments and government security programs. The defining structural characteristic of this market, however, is one that most promotional coverage elides: it is already dominated by a competitor with structural economics so superior that no other company has successfully challenged its position. SpaceX executes over 100 launches per year with reusable Falcon 9 boosters whose per-launch marginal cost is a fraction of any competitor, generates billions annually from Starlink, and has a captive internal demand base that keeps its production machinery running at a cost basis no external competitor can match. Every other launch provider — Rocket Lab, United Launch Alliance, Blue Origin — is competing for the residual market that SpaceX does not choose to serve, or for government programs that specifically require a second provider for strategic redundancy. The market is large and growing. The competitive structure is not favorable for anyone except the incumbent.
Rocket Lab was founded by Peter Beck in New Zealand in 2006, went public via SPAC in 2021, and has since assembled a business with two distinct segments. The launch segment operates the Electron rocket — a small-lift vehicle capable of delivering approximately 300 kg to low earth orbit on dedicated missions — and has grown its launch cadence from 9 missions in 2022 to 21 missions in 2025, achieving 100% mission success in its most recent full year. The space systems segment, which now represents approximately 74% of total revenue, manufactures spacecraft, satellite components, optical systems, and solar panels for external customers including the Department of Defense, NASA, and commercial satellite operators. The December 2025 SDA contract for 18 missile-warning satellites at $816 million — the company's largest single contract in history — and the March 2026 HASTE contract for $190 million in hypersonic test launches together illustrate the company's successful positioning as a trusted U.S. government space prime. This is a real business executing operationally.
The moat argument for Rocket Lab's existing operations is specific and limited. Electron has the best small-satellite launch track record of any dedicated small-lift provider: three times more successful launches than its nearest category competitor as of early 2026. The company's status as a U.S.-headquartered, U.S.-manufacturing-intensive defense prime creates a meaningful barrier against foreign competitors in national security programs. The Space Systems business has accumulated deep technical relationships with the SDA and NASA that are genuine and not easily replicated by a new entrant. None of this is illusory. But these competitive positions collectively support a business doing $600 million in annual revenue — not a $38.8 billion enterprise. The gap between what the current moat justifies and what the current market cap implies is measured in one thing: the Neutron medium-lift rocket that has not yet flown.
Neutron is designed to carry approximately 13,000 kg to low earth orbit — thirteen times Electron's payload capacity — and is targeted for its first launch in Q4 2026. If successful, Neutron would qualify Rocket Lab for the National Security Space Launch Lane 1 program, an indefinite-delivery/indefinite-quantity contract valued at $5.6 billion over five years, which SpaceX and ULA currently share. A credible second entrant in medium-lift launch would be transformative for Rocket Lab's revenue potential and unit economics. This is the bull case, and it is coherent. The problem is that this bull case is not merely priced into the stock — it appears to be already discounted with the assumption of success, and then some. Neutron has not flown. Its first-stage tank test failed due to a manufacturing defect by a contractor. The Q4 2026 target is achievable, but rocketry development timelines have a consistent historical pattern of slipping, and a single catastrophic failure on an inaugural flight — a well-documented category risk — would reset the thesis entirely.
The financial numbers show the structure of the bet the current shareholder is making.
| Year | Revenue ($M) | Adj. EBITDA ($M) | Backlog ($B) | ATM Equity Raised ($M) | Launches |
|---|---|---|---|---|---|
| FY2022 | ~$211 | ~$(60) | n/a | ~$25 | 9 |
| FY2023 | ~$245 | ~$(70) | ~$0.6 | ~$0 | 10 |
| FY2024 | ~$437 | ~$(130) | ~$1.07 | ~$300 | 16 |
| FY2025 | $602 | $(182) | $1.85 | $1,146 | 21 |
The left side of the table is unambiguously good: revenue growing from $211 million to $602 million in three years, backlog more than doubling year-over-year to $1.85 billion, launch cadence growing from 9 to 21 per year. The right side is the structural problem: adjusted EBITDA losses are widening, not narrowing, even as revenue scales; and the equity dilution, modest in 2022 and 2023, erupted to $1.15 billion in 2025 — nearly twice the company's annual revenue — and continues with another $1 billion offering already announced for 2026. The EBITDA trajectory is an investment-driven loss (Neutron development, the Mynaric acquisition integration), not an operational deterioration. But the distinction matters less than it appears: whether the losses are good-investment losses or bad-operational losses, the shareholders bear the dilution required to fund them, and at the current pace of capital consumption, the number of shares that will exist when profitability is eventually reached is substantially larger than the number that exist today.
The dilution arithmetic is the case against ownership at current prices in its most concentrated form. In 2025 alone, Rocket Lab raised $1.146 billion through its at-the-money equity program — shares sold continuously into the market to fund operations. The company has guided a cash burn rate of $45 to $50 million per quarter and stated that free cash flow positivity is "several years away." If that means three years from today, the additional dilution to reach FCF breakeven is approximately $540 to $600 million at current burn rates, on top of the $1.15 billion already raised in 2025 and the $1 billion raised in early 2026. The investor who buys Rocket Lab today is a minority partner in a joint venture with the future share issuances required to fund Neutron development — and those future issuances rank ahead of today's shareholders in capturing the eventual value creation.
Peter Beck is a legitimately impressive aerospace entrepreneur. The operational track record — building a launch vehicle from scratch, achieving 100% mission success across 21 launches in a single year, winning the SDA's largest satellite system contract — reflects genuine technical and organizational capability that few companies have demonstrated in the commercial space era. Capital allocation, however, is a different assessment: the company has chosen to fund its ambitions through continuous equity issuance rather than building toward internal cash generation first, and the CFO selling over $103 million in shares in January 2026 — at a time when the company was simultaneously raising $1 billion from external shareholders through its ATM program — is an insider signal that deserves direct acknowledgment rather than rationalization. A CFO who sells $103 million in a company's stock while the company asks external investors to buy $1 billion more of the same stock is expressing a view about relative value that the investing public can read plainly.
The backlog of $1.85 billion growing 73% year-over-year represents approximately three years of revenue at current run rates, a genuine and meaningful indicator of contract momentum. Rocket Lab has captured significant government customer relationships that are not easy to replicate. The question of market penetration for the existing Electron-and-Space-Systems business is secondary to the Neutron question: Electron can realistically achieve 25 to 30 launches per year at its current cadence, and at $7 to $8 million per Electron launch, the practical revenue ceiling for the launch segment is roughly $200 to $250 million annually — a real business, but not a $38 billion business. The Space Systems segment has more runway: if Rocket Lab wins additional SDA and national security satellite programs and grows to $1 to $1.5 billion in space systems revenue with improving margins, the standalone business might justify an enterprise value of $5 to $8 billion in a reasonably optimistic scenario. The remaining $30 billion in enterprise value is entirely a bet on Neutron, NSSL qualification, and the company's ability to compete against SpaceX in medium-lift launch over the next decade.
At current prices near $70 per share, Rocket Lab trades at an enterprise value of approximately $38.8 billion on $602 million in trailing twelve-month revenue — a ratio of 64.5 times sales. The company has no earnings to anchor a P/E multiple. The EV/EBITDA ratio is negative because EBITDA is negative. Free cash flow is deeply negative. The valuation is pure narrative: Neutron works, wins NSSL, captures meaningful share of medium-lift launch, and the company eventually generates margins sufficient to justify the price paid today. That scenario is possible. The question for the investment is whether the current enterprise value gives adequate compensation for the probability that it does not materialize — or materializes more slowly and with more dilution than the current price implies. The answer is no: the enterprise value has already priced in the success, and the ongoing dilution ensures that the actual shareholders who benefit from that success will not primarily be those who bought at $70.
The most intelligent bear on this stock would say: the Electron business is not a moat — it is a subscale position in a market dominated by a competitor with incomparably better economics, and the entire thesis depends on a rocket development program that has already failed a tank test. The answer is that Electron has genuine competitive advantages within the small-satellite dedicated launch segment, and the government contract momentum is real. But the bear's core point — that the valuation is pricing in Neutron success, not Electron success — is correct, and it is the most important fact about the stock.
For the thesis to change, the first Neutron launch would need to succeed, and the NSSL Lane 1 qualification would need to follow. Those events would provide direct evidence that the $38.8 billion enterprise value reflects something actually demonstrated rather than merely projected. Until then, the buyer is taking on the full risk that the catalyst either doesn't arrive or arrives after years of additional dilution at prices that make the original entry irrelevant.
The operations are real. The contracts are real. The rocket that justifies the price is not yet.
Was this analysis useful?